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1 Zusammenfassung 
Ziel dieser Arbeit war es festzustellen, ob eine transiente Infektion mit dem Bovinen Virusdiarrhoe 
Virus (BVDV) einen Einfluss auf die tägliche Gewichtszunahme von neuseeländischen Kälbern 
fleischbetonter Rassen hat. Dazu wurde 1174 Kälbern von 7 verschiedenen Betrieben auf der Nord- 
und Südinsel Neuseelands zweimal Blut genommen und mittels eines Antikörper-ELISA Tests ihr 
Serostatus bestimmt. Das Gewicht der Kälber wurde dreimal gemessen, das erste Mal im Alter von 2- 
7 Monaten, dann mit 4-8 Monaten und das letzte Mal dritten Mal mit 12-18 Monaten. Aus diesen 
Werten wurde ihre tägliche Gewichtszunahme berechnet. Eine durchgestandene transiente Infektion 
definierten wir als ein positives ELISA Ergebnis bei der zweiten Blutprobe. Beim Vergleich der 
täglichen Gewichtszunahme seropositiver Tiere mit derjenigen seronegativer Tiere konnten wir keinen 
statistisch signifikanten Unterschied feststellen. Wir schliessen daraus, dass eine transiente Infektion 
mit dem BVD Virus keinen deutlichen Einfluss auf die Gewichtszunahme von Fleischkälbern hat.  
 
 
2 Abstract 
AIM: To assess if a transient infection with bovine viral diarrhoea virus is affecting the daily weight 
gain of beef calves in New Zealand. 
METHODS: 1174 beef calves of 7 farms on the North and South Island of New Zealand were weighed 
3 times and tested twice for BVD induced antibodies (ab ELISA). 
RESULTS: No significant association was detected between transient BVD infections and daily weight 
gains of beef calves in this study. 
CONCLUSION: Transient infections with BVDV do not seem to have any remarkable impact on daily 
weight gains of beef calves. 
KEY WORDS: BVD, beef calves, average daily weight gains, transient infection 
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3 Introduction 
Bovine viral diarrhoea virus (BVDV) is a virus known worldwide, causing major economic losses in 
dairy and beef production.  
An infection of a pregnant cow with the virus can either result in the resorption of the embryo, 
immunological tolerance of the foetus, abortion, stillbirth, malformation or in the birth of a healthy 
seropositive calf. Non-pregnant susceptible cattle that are infected with the BVDV undergo a period of 
transient viremia. They will either show clinical signs of a mild acute gastroenteritis with diarrhoea, 
fever, nasal discharge, cough and anorexia or not show any clinical signs. Subsequently, they will 
respond with a strong immune response and produce enough neutralizing antibodies to eliminate the 
virus and be protected from further infections with the same BVD strain. These animals are referred to 
as transiently infected animals. Immunologically tolerant calves however, called persistently infected 
(PI) calves, act as a virus reservoir for the rest of their lives, shedding it with all secretions and excretions, 
potentially infecting other cattle. PI animals might appear weaker, smaller and more susceptible to 
diseases such as respiratory diseases but often they do not show any clinical signs at all (Selbitz et al 
2007; Anonymous 2011). 
Economic costs caused by BVDV vary strongly depending on the pathogenicity of the virus strain as 
well as on the herd immunity and on the stage of breeding cycle when the infection occurs. 
Nevertheless it is estimated that per million calvings the annual loss is between USD 20Mio and 57Mio 
(Houe 1999). In New Zealand, economic losses caused by BVDV are estimated to 45Mio NZD per year 
or 87 NZD per cow and year for dairy industry alone. This amount arises from increased abortion and 
calving induction rates, increased time from calving to conception as well as decreased milk production 
(Heuer et al 2007). According to different calculations, the annual costs of BVD in an average sized (322 
milking cows) New Zealand dairy herd amount to 11’334 NZD or 35.19 NZD per cow and year (Reichel 
et al 2008). As for the beef industry, a mean loss of about €58 per cow and year (abortion, conception 
failure, re-absorption) was estimated using an epidemiological outbreak model in Scotland (Gunn et al 
2004). Furthermore, the majority of New Zealand adult cattle, around 60%, are thought to carry 
antibodies against BVDV (Littlejohns and Horner 1990) and up to 14.6% of the dairy herds are infected 
meaning that there are PI animals among them (Thobokwe et al 2004).  
Due to considerable financial losses several European countries started to control and eradicate BVD. 
In Scandinavia, a two-stage eradication programme was implemented; in a first step, infected herds 
were identified by serological tests, in a second step all animals of an infected herd were tested and the 
virus-carrying animals were removed. Subsequently, non-infected herds were monitored by repeated 
sampling (Lindberg and Alenius, 1999). Currently, all Scandinavian countries are either free or almost 
free from BVD (Ståhl and Alenius, 2012). 
In Switzerland, an eradication program was carried out from 2008-2012. Firstly, all bovines that went 
to summer pasture were sampled and tested for the virus before leaving. Within one year, the whole 
cattle population of Switzerland was sampled and tested for the virus. In the next phase (2009-2012), 
ear notches of every new born calf were taken and tested. Since 2013, the BVD free status of the herds 
is monitored by bulk tank milk or blood samples (non-lactating bovines) (Presi 2010). In New Zealand, 
control of BVD is based on voluntary, individual testing and eradication of PI animals as well as 
vaccinating against the disease. Efforts to eradicate New Zealand from BVD are in progress but to the 
authors knowledge no nationwide eradication programme has been started yet. 
Whereas the effect of persistent infection with BVDV on animal performance has been studied 
intensively, information regarding the effect of transient infection on the average daily weight gains of 
beef calves is scarce. The aim of this study was therefore to assess if a transient BVDV infection is 
significantly associated with average daily weight gain in beef calves in New Zealand.  
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4 Material and Methods 
Study animals 
The animals in this study were originally targeted and sampled for a study on production effects of 
leptospirosis infection in calves, heifers, lambs and deer: “Effects of leptospirosis on pastoral livestock 
production in New Zealand” (provisional title, Emilie Vallee, unpublished data). The farms were 
chosen due to their size and proved presence of leptospirosis. Overall 1174 beef calves (Angus, Salers, 
Hereford, South Devon, Shorthorn and Crossbred animals) on 7 farms in 4 different districts (2 in 
Wairoa, 2 in Manawatu, 2 in Hurunui, 1 in Tararua district) on North and South Island of New Zealand 
were enrolled in this study. Farms were named E1, E2, E3, E4, E6, E7, E8. The calves were chosen 
randomly, not all calves of each farm were included. They were raised as suckler calves and therefore 
fed on milk and grass pasture during the entire time of the study. All calves of farm E7 were vaccinated 
against BVD, the calves of the other farms did not receive a vaccination. However, some of the calves’ 
dams (all heifers of farm E2 and E6) were vaccinated at mating. Exact weaning dates of the calves are 
unknown but in general weaning dates of 5 to 7 months of age with a mean of 6 months can be assumed. 
 
Study design and sample collection 
Blood samples of all calves were collected twice and weights measured three times starting in 
November 2011 and continuing through April 2013. The blood samples were tested for BVDV induced 
antibodies (ab ELISA). Average daily gains were calculated for each animal. Finally, average daily 
weight gains of seropositive calves were compared to those of seronegative calves.  
The study was designed as a cross-sectional study. Based on the ELISA result the animals were either 
classified as seropositive, seronegative or equivocal. 
The calves were between 2 and 7 months of age when the first blood samples and first weights were 
recorded. Last blood samples and weights were collected when the calves were between 12 and 18 
months of age. They were collected on the same day except on farm E1 where the last weights were 
measured approximately 4 months after the second blood samples were taken. 
Weights were measured with the farmers own scales before releasing the animals back to their herd.   
Average daily gains were calculated for the period between first and third weight sampling (Adg1) 
and between second and third weight sampling (Adg2).  
Blood samples were collected at the caudal vein using Red Top Vacutainers® and 20Gx1’’ Vacutainer 
needles. The visual ID (ear tag) of each animal was written on its blood collection tube. The blood was 
allowed to clot and processed within 24h for serum collection. It was then stored at -20°C.  
 
Serologic testing 
The serum samples were tested by NZVP laboratories (New Zealand Veterinary Pathology Ltd) at 
Massey University in Palmerston North. An IDEXX BVDV p80 Ab Test® was carried out to detect BVD 
specific antibodies. The cut-offs for percentage inhibition were defined as recommended by the 
manufacturer as follows:  
≥50 percentage inhibition (%INH) was considered as a negative result, 40-50% INH as 
doubtful/equivocal and <40% INH as a positive result.  
A positive ELISA at the time of the second sampling was considered as indicative for a transient BVDV 
infection. 
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If equivocal results were added to positive results, it will be referred to as Spos, if they were added to 
negative results, it will be referred to as Sneg. The distinction was made for a sensitivity analysis of the 
results. 
 
Statistical analysis 
Statistical analysis was performed with the software R version 3.1.0 and the package nlme (Pinheiro et 
al. 2014). 
With the aim to assess a potential association between serostatus and average daily weight gain, linear 
mixed effects models were used. The response variables were: Adg1, Adg2. The prediction variables 
were serostatus (Spos, Sneg or %Inhibition) and sex (F, M, MD (male - docked)), as fixed effects and 
farm as random effect. Model selection (inclusion of serostatus yes or no) was based on AIC (Akaike 
information criterion) and a likelihood ratio test of nested models was used to evaluate whether fixed 
or random effects significantly improved the model fit. Residuals were visually inspected for 
homoscedasticity, normal distribution of residuals and influential observations.  
 
 
5 Results 
The final analysis included 738 calves from 1174 initially enrolled calves with complete data on Adg1 
and Adg2, sex, farm and serostatus. The remaining 436 animals were excluded mostly due to the last 
weight and/or blood sample being missing from farm E2.  
The raw data (number of animals, number of females, males and docked males, serostatus, average 
daily weight gains as well as mean and standard deviation per farm) are summarized in Table 1. 
On farm E1, nearly all calves were female. Two farms, E4 and E8, neutered their male calves whereas 
E3, E6 and E7 left the male calves intact. The calves of E1 as well as E3 had similar proportions of sero-
positive and seronegative calves at last sampling. However, the calves of E6, E7 and E8 were mainly 
seronegative, whereas on farm E4, nearly all animals were seropositive, hence within farm comparisons 
in these groups had low statistical power or were not possible at all. The overall average daily weight 
gain (Adg1) was around 600g for farms E1, E3, E4 and E6. Farm E7 with a mean of nearly 900g was 
considerably higher and E8 with 519g somewhat lower than the other farms.  
Although the serostatus at the time of the second sampling was found to be significantly associated 
with average daily weight gains 1 and 2 (Figure 1), this association disappeared if farm was included 
in the model (either as fixed or as random effect, Figure 2). Similarly, no significant association was 
found between percentage inhibition and average daily weight gains if the effect of farm was included. 
Since one farm (E7) showed higher average daily gains (Figure 1) and had mostly negative animals, an 
analysis with a subset (only farm E1 and E3 which had both seronegative and seropositive animals) 
was performed to separate farm and a potential serostatus effect on weight. Again, serostatus was not 
significantly associated with average daily weight gains (Figure 3). The p-values are shown in Table 2. 
 
 
6 Discussion 
The aim of this study was to assess whether there was a significant change in average daily weight gain 
in beef calves that were suspected to have had a transient infection with BVDV prior to weighing, 
compared to beef calves without any signs of a past infection. Calves from 7 beef calf herds throughout 
New Zealand have been weighed and tested for BVDV induced antibodies. Daily body weight gains 
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of seropositive and seronegative calves were compared statistically. This study did not detect 
significant difference in average daily weight gains between calves with or without signs of a BVDV 
infection. However, the study suffered of low power since about 20% enrolled animals had to be 
excluded due to missing data. Moreover, only two farms had similar number of calves in the two 
exposure groups, hence allowed valid intra-farm comparisons. This reduced the statistical power 
further. 
 
Farm effect  
It appeared to be difficult to separate the effect of farm and serostatus. Therefore an analysis with a 
subset consisting of farms E1 and E3 was performed. Again, no association was evident between 
serostatus and daily weight gains. However, a marked effect of the sex was discovered. Male calves 
showed significantly higher weight gains than female calves.  
 
Selection bias 
A possible selection bias cannot be ruled out due to the following reasons: The animals were originally 
chosen for a study on leptospirosis and divided into two groups, of which one group received a vaccine 
against leptospirosis and the other one served as control group. Furthermore we lacked some 
information like BVD vaccination status of the mothers of the calves, biosecurity status of the farms, 
imported animals, calves that were not participating in the study but grazing on the same paddocks as 
the ones participating as well as contact to other herds over the fence. Lastly, we started with including 
1174 calves in our study, but in the end only serum samples and corresponding weights of 738 calves 
could be obtained. Unfortunately many calves were not present at the last sampling (died, sold, 
unknown reasons) and their data was therefore lost. Some of these losses might have been caused by 
infection with BVDV. This loss could have biased the association between serostatus towards the null 
hypothesis of no Adg-difference (‚healthy worker effect‘). Furthermore, no third weight was available 
from farm E2, hence farm E2 did not add any data to the study. 
 
Transient infection 
Transient infection was defined by an ab ELISA positive test result. However, sensitivity and specificity 
do not reach 100% and the results were not corrected for this. A positive test result does not have to be 
a transient infection, e.g. farm E7 with only five positive animals and a history of vaccinating all calves 
where positive titres could have been caused by vaccination. Moreover, there was uncertainty about 
the time of infection since only one sampling was taken into consideration on this farm. It is possible 
that some calves only got the infection a few weeks before the sampling and that there was therefore 
not enough time for developing an effect on weight gain.   
 
Maternally derived antibodies 
Two consecutive blood samples were tested for BVDV induced antibodies. However, only the second 
sample was statistically analysed because antibodies of the first sample might have been the tail end of 
waning maternal antibodies. Calves were between 2 and 7 months of age at the first sampling. Colostral 
BVDV antibody decay may range from 0 to200 days of age. The average half-life for BVD antibodies 
was found to be 20 days. (Menanteauhorta et al 1985). Another study about the decay of maternally 
derived BVD antibodies determined that after 114-141 days of age (depending on the type of BVD) half 
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of the calves in the study became seronegative. They suggested that the rate of decay is strongly 
associated with the initial antibody titre at day 1 to 3 of age (Munoz-Zanzi et al 2002). In view of such 
a large difference between studies, it is possible that some calves that were seropositive at the first 
sampling were carrying maternally derived antibodies. 
 
Vaccine derived antibodies 
All calves of farm E7 received a BVD vaccine as part of the farms management scheme. However, an 
influence of vaccine derived antibodies on the ELISA result seems unlikely as a study demonstrated 
that the commercially available inactivated BVD vaccine Bovilis® (Intervet International, the 
Netherlands) shows properties of a marker vaccine: after vaccinating cattle with a single or double shot, 
NS3 specific antibodies were low or undetectable, whereas after vaccination and subsequent challenge 
with BVD field virus all animals produced antibodies against NS3 and were positive in 4 different 
commercial ELISA tests. Vaccination with Bovilis® BVD does therefore not interfere with the 
development of antibodies after infection with field virus (Makoschey et al 2007). 
  
Previous studies 
Previous research about influence on weight gain associated with transient infection showed varying 
results: One study suggested no significant difference (p >0.05) in average daily gain between calves in 
a pen (feedlots) containing PI animals and calves in a pen without PI animals in the herd. However, all 
calves in this study received a modified-live BVDV vaccine upon arrival at the feedlots and a booster 
vaccine up to 10 weeks later. No statistically detectable difference in morbidity, overall mortality or dry 
matter intake to gain ratio was found (Booker et al. 2008). In a different study, short (60h) or long term 
(entire finishing period 215d) exposure of 288 heifers directly or via adjacent pens to a PI animal did 
not show any significant differences in average daily gain, final body weight or overall efficiency of 
gain compared to non-exposed heifers. In this study as well the heifers received a vaccine against BVD 
before weaning and were given a metaphylactic antibiotic treatment upon arriving at the study site. It 
was suggested that exposing vaccinated heifers to a PI animal did not affect growth performance or 
mortality (Elam et al 2008). However, a tendency of reduced average daily gain (not statistically 
significant p=0.09) over the entire finishing period was shown in a study of 12 unvaccinated steers with 
short time (72h) exposure to PI animal. A long-term negative effect on animal performance after 
exposure was therefore suggested (Burciaga-Robles et al. 2010). Another study showed an exposure 
effect on average daily gains of calves having contact with a PI pen mate: the exposed calves showed 
smaller average daily gains from day 28 to day 42 of the study even though they were vaccinated 
against BVD. They also needed more antibiotic therapy and had more chronically ill animals in the 
same pen compared to calves that were not exposed (Richeson et al. 2012). Lastly, one study showed 
that animals with high antibody titre typically weighed less than animals without evidence of exposure. 
Other factors like stillbirth, abortion rate, calf-death and nonpregnancy however seemed to be the same 
as animals without evidence of exposure (Waldner and Kennedy 2008).  
 
It can be concluded that according to our data there was insufficient evidence for an association 
between serostatus and daily weight gain of beef calves on these New Zealand farms.  
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9 Tables and Figures 
 
Farm N1 Sex2 
F        M      
Spos3 
Pos   Neg 
Sneg4 
Pos     Neg 
Adg15 
Mean (SD) 
Adg26 
Mean (SD) 
E1 72 68 3 11 61 11 61 626g (66) 640g (85) 
E3 179 101 78 115 64 102 77 610g (86) 726g (186) 
E4 170 90 80 167 3 167 3 639g (76) 592g (79) 
E6 96 40 56 0 96 0 96 612g (72) 583g (106) 
E7 184 87 92 6 178 5 179 894g (126) 850g (152) 
E8 37 27 10 0 37 0 37 519g (84) 406g (70) 
Table 1 
1: Number of animals 
2: Female, Male 
3: Serostatus, equivocal results allocated to Positives 
4: Serostatus, equivocal results allocated to Negatives 
5: Average daily weight gains through entire sampling period, mean, standard deviation 
6: Average daily weight gains through second half of sampling period  
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 Spos, (Sex) Sneg, (Sex) %INH, (Sex) 
All farms, Adg1 0.822, (<.0001) 0.723, (<.0001) 0.816, (<.0001) 
All farms, Adg2 0.559, (<.0001) 0.419, (<.0001) 0.563, (<.0001) 
Subset E1+E3, Adg1 0.516, (0.040) 0.994, (0.0355) 0.985, (0.037) 
Subset E1+E3, Adg2 0.917, (0.224) 0.901, (0.215) 0.933, (0.220) 
Table 2: p-values  
 
 
 
Figure 1 
Average daily gains during the entire samplng period (November 2011- April 2013), which corresponds to Adg1.  
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Figure 2 
Comparing antibody positive and negative calves (all farms, Sneg) during the entire sampling period, which corresponds to 
Adg1. 
 
 
Figure 3 
Comparing antibody positive and negative calves of farms E1 and E3 (subset, Sneg) during the entire sampling period, which 
corresponds to Adg1. 
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